Peptide R

Price range: $41.00 through $229.00

Alternative Name: Pep R
Commonly Listed CAS #: 1318232-11-9 (TFA salt; verify against COA)
Molecular Formula: C₃₉H₅₇N₁₃O₈S₂ (listed TFA-associated record)
Molecular Weight (M.W.): Approximately 900.1 g/mol (listed TFA-associated record)
Sequence: Arg-Ala-Cys-Arg-Phe-Phe-Cys
One-Letter Sequence: RACRFFC
Length: 7 amino acids
Structural Feature: Disulfide bridge between Cys3 and Cys7
Product Type: Cyclic Synthetic Research Heptapeptide

Peptide R, also referred to as Pep R, is a synthetic seven-amino-acid peptide supplied for controlled laboratory, analytical, and scientific research.

Its defined sequence is:

Arg-Ala-Cys-Arg-Phe-Phe-Cys

or:

RACRFFC

A key structural characteristic of Peptide R is the intramolecular disulfide bridge between the cysteine residues at positions 3 and 7, which creates a constrained cyclic region within the peptide. PubChem represents the peptide as H-Arg-Ala-Cys(1)-Arg-Phe-Phe-Cys(1)-OH, with the two cysteine residues connected by the disulfide linkage.

Because commercial Peptide R may be supplied as a TFA-associated preparation or another counter-ion form, final molecular specifications should always be verified against the lot-specific Certificate of Analysis.

Research Applications

Peptide R may be examined in controlled non-clinical research involving:

  • Cyclic peptide characterization
  • Ligand-receptor interaction studies
  • Molecular binding research
  • Structure-function analysis
  • Disulfide-constrained peptide studies
  • Analytical peptide comparison
  • Stability assessment
  • Non-clinical biochemical and cellular models

Published research has used Peptide R in studies involving CXCR4-associated molecular systems, but these findings should remain confined to the applicable experimental models and should not be interpreted as evidence of therapeutic or clinical effectiveness.

Structural Information

Peptide R contains seven amino-acid residues:

Arg-Ala-Cys-Arg-Phe-Phe-Cys

One-letter sequence:

RACRFFC

Structural representation:

H-Arg-Ala-Cys(1)-Arg-Phe-Phe-Cys(1)-OH

The peptide contains a:

Cys3–Cys7 disulfide bridge

This disulfide linkage forms part of the compound’s defined molecular identity and should be retained in technical documentation.

Salt-Form Considerations

A commonly listed Peptide R record is associated with a TFA preparation and reports:

  • CAS #: 1318232-11-9
  • Molecular Formula: C₃₉H₅₇N₁₃O₈S₂
  • Molecular Weight: Approximately 900.1 g/mol

Because counter-ion and salt form can affect reported molecular specifications, these values should not automatically be applied to a product supplied in a different chemical form.

Analytical Identification

Relevant analytical characterization may include:

  • Amino-acid sequence confirmation
  • Disulfide-bond verification
  • Molecular mass assessment
  • Counter-ion identification
  • Chromatographic purity analysis
  • Structural characterization
  • Lot-specific analytical testing

The Cys3–Cys7 disulfide linkage should be considered when confirming the product’s structural identity.

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Product identity
  • Amino-acid sequence
  • Disulfide configuration
  • CAS number
  • Molecular formula
  • Molecular weight
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific analytical documentation should take precedence over generalized reference data.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that may compromise peptide integrity or disulfide stability.

Handling should follow established laboratory procedures appropriate for research materials.

Research Use Only

Peptide R is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, oncology-related use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, anticancer, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.